# Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma

> **NCT02977702** · — · COMPLETED · sponsor: **Institut de Cancérologie de Lorraine** · enrollment: 114 (actual)

## Conditions studied

- Pancreatic Neoplasms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02977702
- **Lead sponsor:** Institut de Cancérologie de Lorraine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2016-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02977702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02977702, "Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02977702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*